Grants

Current Grants for Dr. Ambarish Pandey

Source Topic Years
Ultromics Prevalence and Prognostic Implications of an Artificial Intelligence-based Echocardiographic Tool to Diagnosis HFpEF in a Large Health System NEW
Ultromics Identifying Undiagnosed HFpEF among Patients with Type 2 Diabetes using Ultromics AI HFpEF Algorithm NEW
NHLBI 1R21HL169708-01 Cardiac biomarkers, intensive blood pressure treatment and risk of adverse cardiovascular outcomes in type 2 diabetes, a secondary analysis of the ACCORD BP NEW
American Heart Association 24HCMFLP1284773 Hypertrophic Cardiomyopathy Federated Learning Platform NEW
American Heart Association 24RPGFIM1198188 Examining the Impact of Medically Tailored Meals vs Produce Supplements Delivered Conditionally vs Not on Heart Failure NEW
NIH R01 MD017529 Polypill strategy for the evidenced-based management of heart failure with reduced ejection fraction in an underserved patient population 2022-2026
SC Pharmaceuticals, Inc - Investigator Initiated Study Role of subcutaneous furosemide to augment diuresis in heart failure patients with diuretic resistance: A randomized controlled trial 2023-2024
American Heart Association Telemedicine Enabled Care Quality Improvement Among Rural Patients with Heart Failure: The Rural-HF Project Grantor  
American Heart Association Machine Learning-based Models with Social Determinants of Health to Improve Incident Atrial Fibrillation Prediction  
Roche Diagnostics
(investigator-initiated study)
Cardiovascular Biomarkers and heart failure risk in Diabetes  

Previous Grants

Source Topic Years
Applied Therapeutics Inc. - Investigator Initiated Study Prevalence of diabetic cardiomyopathy and its association with risk of heart failure in the community
To evaluate the prevalence of diabetic cardiomyopathy and its association with incident heart failure in the pooled epidemiological cohorts and the electronic medical records-based registry of patients with type 2 DM at UT Southwestern.
2022-2023
NIH R03 AG067960 Evaluation of Racial Differences in Cardiorespiratory Fitness Decline with Aging & Underlying Biological Mechanisms 2020-2022
Gilead Sciences Inc. - Gilead Research Scholars Association Between Baseline and Longitudinal Changes in Hepatic Steatosis with Cardiac Structure, Function, and Myocardial Injury Burden in a Multi-Ethnic Cohort of Middle-Age Adults
To evaluate the association of subclinical hepatic steatosis, as assessed by MRI spectroscopy, with abnormalities in cardiac structure and function, as assessed by cardiac MRI, and myocardial injury in a well-phenotyped of the Dallas Heart Study.
2020-2022
Texas Health Resources - Clinical research scholarship Novel approaches to prediction and prevention of heart failure
To develop novel, EMR-based approaches to predicting risk of heart failure and implementing clinical decision support tools to increase uptake of effective approaches for heart failure prevention.
2018-2022

 

Current Grants for Dr. Thomas Wang

Source Topic Years
NIH R01-DK108159 Metabolic profiles and the risk of diabetes in Asians 2016-2022
NIH R01-DK081572 Metabolic predictors of Insulin resistance and diabetes 2008-2026
Leducq Foundation Transatlantic Network of Excellence Brown fat and cardiovascular health  
NIH R01 MD017529 Polypill strategy for the evidenced-based management of heart failure with reduced ejection fraction in an underserved patient population 2022-2026

Previous Grants

Source Topic Years
R01 HL133860 Tissue Sodium, Inflammation, and Blood Pressure in MESA 2016-2021
NIH R01-HL128983 PDE5 Inhibition for Obesity-Related Cardiometabolic Dysfunction 2016-2021
NIH R01-HL133870 Aptamer Proteomics of Cardiometabolic and Renal Traits in African Americans 2017-2021
NIH T32-HL007411 Training in Cardiovascular Research 1994-2020
NIH K12-HL133117 The Vanderbilt Emergency Care Research Training Program 2016-2020